Euthare-155008

ETH-155008 · Shengke Pharmaceuticals (Jiangsu) Limited

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Euthare-155008, covering 2024-05-08 to 2024-05-08. Get the full timeline:

Most recent: Clinical Trial Update: A Phase I Study of Euthare-155008(ETH-155008) in AML and NHL Patients [Phase 1]